Bimeda is pleased to announce the launch of Tetracure injection (200mg/ml oxytetracycline, POM). The range is the latest addition to the company’s broad and expanding veterinary pharmaceuticals range.
Sales Manager for Bimeda Ireland, Andrew Glynn, commented; ‘the launch of Tetracure highlights our ongoing commitment to providing Irish veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price.’
Tetracure injection is indicated in the treatment and control of diseases caused by, or associated with, organisms sensitive to Oxytetracycline in cattle, sheep and pigs.
Benefits of Tetracure include:
High syringe-ability: the product injects well event at cold temperatures.
Flexibility: Tetroxy Vet is licensed for use in cattle, sheep and pigs and can be administered to lactating animals
Fast-acting, yet long-acting: Tetroxy Vet provides rapid initial blood levels of oxytetracycline, followed by a long-acting effect.
Tetracure is available in a 100ml pack size.
Bimeda manufactures a wide range of veterinary pharmaceuticals and animal health products. In Ireland, the company is known for its dry cow intramammary range, including Boviseal teat sealant, as well as Kefamast, Bovimast and Multimast dry cow antibiotic tubes. The company is also a leading manufacturer of anti-parasitic products, such as Dectospot (Deltamethrin 10mg/ml), Ectofly (1.25% Cypermethrin) and Bimectin Plus (Ivermectin 10mg/mL and Clorsulon 100mg/ml)
For further information on any Bimeda product, contact your local Bimeda Sales Representative or call Bimeda on Lo Call 1850 51 52 53.
Use Medicines Responsibly.
Date press release prepared: July 2016. For full product information, including contra-indications, see the data sheet which can be found on Bimeda.ie. Bimeda can be contacted on Lo Call 1850 51 52 53